ADPKD

Is Metformin Now in Our Armamentarium for Autosomal Dominant Polycystic Kidney Disease (ADPKD)?

September 7, 2022 // 0 Comments

Orhan Efe @OrhanEfe_ Dr. Orhan Efe is a Nephrologist at Massachusetts General Hospital in Boston, MA. Dr. Efe was an AJKD Editorial Intern from 2021-2022. He is passionate [...]

Highlights from the April 2022 Issue

April 1, 2022 // 0 Comments

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]

Renal Ciliopathies: A Pediatric Nephrology Perspective

February 3, 2021 // 1 Comment

The non-motile primary cilium, a specialized organelle found in nucleated mammalian cells, plays an important role in human biology due to its pleiotropic effects. This [...]

#NephMadness 2020 The Impact of Genetic Testing on A Person: A Patient Perspective

March 31, 2020 // 0 Comments

@KidneyRebel is a patient with ADPKD who wishes to remain anonymous at this time for personal reasons. They are a staunch advocate for progress and innovation in nephrology [...]

Clinical Trial End Points in ADPKD

June 6, 2019 // 0 Comments

Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. [...]

Predicting Polyuria: Can We Help Patients with ADPKD Better Tolerate Tolvaptan?

May 6, 2019 // 0 Comments

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, often results in the need for renal replacement therapy, and is the etiology [...]

Advancing Patient-Centered Care in Autosomal Dominant Polycystic Kidney Disease

January 25, 2018 // 1 Comment

In a recent study published in AJKD, Oberdhan et al (Open Access) discuss the development of a new health-related quality of life (HRQoL) tool for patients with Autosomal [...]